生命科学资讯

Cytiva develops two new protein A resins bringing cost efficiency to mAb capture - BioSpectrum India

Roche, answering tariff threat, pledges $50B to US drug production - BioPharma Dive

Roche looks to expand and upgrade US research centers as part of $50B investment strategy in the country - Fierce Biotech

Roche to invest $50 billion in US to avoid Trump tariffs, create 12,000 jobs - Reuters

Roche follows peers with $50B investment in US manufacturing, research sites - FirstWord Pharma

Cytiva expands portfolio with new MabSelect Resins made from renewable agarose for scalable, cost-efficient mAb manufacturing - Express Pharma

Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs - PharmTech.com

Unlocking the Potential of PROTACs in Drug Discovery - Technology Networks

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - PR Newswire

Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - BioSpace

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines - Contract Pharma

Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - GEN - Genetic Engineering and Biotechnology News

Catching up with Lonza Capsules and Health Ingredients - Nutritional Outlook

Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing - DCAT Value Chain Insights

Cytiva expands MabSelect resin portfolio with new solutions for cost-effective and scalable mAb purification - BioSpectrum Asia

SBTi validates Roche’s net-zero targets - Roche

Lonza Implements Streamlined Operating Model - Contract Pharma

Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC - PR Newswire

Illumina Connected Multiomics - Illumina